(NASDAQ: QDEL) Quidelortho's forecast annual revenue growth rate of 2.74% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.71%.
Quidelortho's revenue in 2025 is $2,714,400,000.On average, 10 Wall Street analysts forecast QDEL's revenue for 2025 to be $187,219,324,240, with the lowest QDEL revenue forecast at $179,135,470,980, and the highest QDEL revenue forecast at $194,148,341,320. On average, 10 Wall Street analysts forecast QDEL's revenue for 2026 to be $192,178,326,660, with the lowest QDEL revenue forecast at $182,192,390,280, and the highest QDEL revenue forecast at $201,281,153,020.
In 2027, QDEL is forecast to generate $200,669,769,160 in revenue, with the lowest revenue forecast at $190,344,175,080 and the highest revenue forecast at $210,519,842,460.